Checkpoint inhibitor therapy and psoriasis: a case series
BRITISH JOURNAL OF DERMATOLOGY(2023)
摘要
Checkpoint inhibitor therapy (CPI) has significantly improved overall survival in several cancers, including metastatic melanoma and in the adjuvant setting. Cutaneous immune-related adverse events secondary to CPI are commonly observed; however, the development of psoriasis or exacerbation of existing psoriasis has not been widely reported and management can be challenging.
更多查看译文
关键词
psoriasis,checkpoint inhibitor therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要